Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 9
Results: 23
Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Rheumatoid arthritis market.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Protein methyltransferases as a target class for drug discovery.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Neurodegenerative disorders: Avoiding bad complement in Alzheimer's disease.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 697, doi. 10.1038/nrd2975
- By:
- Publication type:
- Article
Ageing: Secrets of a long life.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 698, doi. 10.1038/nrd2976
- By:
- Publication type:
- Article
Obesity: A two-pronged attack.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 698, doi. 10.1038/nrd2977
- By:
- Publication type:
- Article
Metabolic disorders: Finding the T in fat.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 699, doi. 10.1038/nrd2978
- By:
- Publication type:
- Article
Neurodegenerative disorders: Discouraging transplant results.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 700, doi. 10.1038/nrd2979
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 700, doi. 10.1038/nrd2980
- Publication type:
- Article
Golimumab.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Trial watch: BLYS-targeted antibody shows promise in Phase III SLE trial.
- Published in:
- 2009
- Publication type:
- journal article
Deal watch: BMS bets on biologic immunotherapies.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 688, doi. 10.1038/nrd2985
- Publication type:
- Article
Market watch: Sales trends by therapeutic area: 2008–2013E.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 689, doi. 10.1038/nrd2986
- By:
- Publication type:
- Article
Research in the charity sector.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 751, doi. 10.1038/nrd2987
- Publication type:
- Article
An audience with...Sir Michael Rawlins.
- Published in:
- 2009
- By:
- Publication type:
- Interview
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 690, doi. 10.1038/nrd2990
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 679, doi. 10.1038/nrd2991
- Publication type:
- Article
Tackling trial troubles.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 681, doi. 10.1038/nrd2992
- Publication type:
- Article
Defining innovation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Rethinking therapeutic cancer vaccines.
- Published in:
- 2009
- Publication type:
- journal article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 9, p. 687, doi. 10.1038/nrd2995
- Publication type:
- Article